Synthesis, Characterization, and Antibacterial Evaluation of a Chromium(III) Schiff Base Complex Derived from Trimethoprim and Benzaldehyde
Communication in Physical Sciences · 2026 · 13 (5) · 695-705
DOI: 10.4314/cps.v13i5.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Communication in Physical Sciences, 2026. Verfasst von Lord Okechukwu Chimereoke Ubani und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The escalating global crisis ofantimicrobial resistance (AMR) necessitatesthe development of novel therapeutic agentswith improved efficacy and alternativemechanisms of action. In this study, a Schiffbase ligand derived from trimethoprim(TMP) and benzaldehyde (BADA),designated TMP-BADA, together with itschromium(III) complex [Cr(TMP-BADA)Cl],was successfully synthesized and evaluatedfor antibacterial activity. TMP-BADA wasobtained as a brown amorphous solid with ayield of 72% and a melting point of 278–280°C, while the Cr(III) complex was isolated asa green powder in 80% yield with adecomposition temperature of 268–270 °C.Spectroscopic characterization by FT-IR and¹H NMR confirmed Schiff base formation andmetal coordination. The disappearance of thealdehydic ν(C=O) band of benzaldehyde at1700 cm⁻¹ and the appearance of a newazomethine ν(C=N) band at 1655 cm⁻¹confirmed imine formation, whilecoordination to Cr(III) was evidenced by ashift of the ν(C=N) band to 1621 cm⁻¹together with perturbations in ν(N–H) andν(C–O–C) vibrations.The antibacterial activities of TMP-BADAand [Cr(TMP-BADA)Cl] were evaluatedagainst Escherichia coli, Pseudomonasaeruginosa, and Staphylococcus aureususing agar well diffusion, minimum inhibitoryconcentration (MIC), and minimumbactericidal concentration (MBC) assays.TMP-BADA exhibited zones of inhibition of32, 35, and 30 mm against E. coli, P.aeruginosa, and S. aureus, respectively, whilethe Cr(III) complex produced inhibition zonesof 27, 40, and 31 mm, respectively. Notably,the Cr(III) complex demonstrated enhancedactivity against P. aeruginosa compared withchloramphenicol (40 vs. 32 mm). MIC valuesranged from 50–100 mg/mL for TMP-BADAand 50–100 mg/mL for the Cr(III) complex,whereas MBC values ranged from 100–200mg/mL. The findings demonstrate that Schiffbase derivatisation of trimethoprim combinedwith transition metal complexationrepresents a promising strategy for thedevelopment of novel metallo-antibacterialagents with enhanced activity againstresistant bacterial pathogens.
Zitieren
APA
Ubani, L. O. C., Mbara, C., & Okezie, C. B. (2026). Synthesis, Characterization, and Antibacterial Evaluation of a Chromium(III) Schiff Base Complex Derived from Trimethoprim and Benzaldehyde. Communication in Physical Sciences, 13(5), 695-705. https://doi.org/10.4314/cps.v13i5.2
Vancouver
Ubani LOC, Mbara C, Okezie CB. Synthesis, Characterization, and Antibacterial Evaluation of a Chromium(III) Schiff Base Complex Derived from Trimethoprim and Benzaldehyde. Communication in Physical Sciences. 2026;13(5):695-705. doi:10.4314/cps.v13i5.2
BibTeX
@article{Ubani2026,
author = {Ubani, Lord Okechukwu Chimereoke and Mbara, Chigozie and Okezie, Chimuanya Benjamin},
title = {Synthesis, Characterization, and Antibacterial Evaluation of a Chromium(III) Schiff Base Complex Derived from Trimethoprim and Benzaldehyde},
journal = {Communication in Physical Sciences},
year = {2026},
volume = {13},
number = {5},
pages = {695--705},
doi = {10.4314/cps.v13i5.2}
}
EUVIMED